Patient Retention in a Substance Use Disorder Telemedicine Clinic

South Med J. 2024 Jul;117(7):374-378. doi: 10.14423/SMJ.0000000000001709.

Abstract

Objectives: Although research has continued to show that substance use disorders (SUDs) can be treated effectively with evidence-based treatment, there continues to be gaps in access, and utilization remains low. Alternative SUD treatment methods, including telemedicine, are increasingly being explored to reach patients where traditional in-person treatment approaches are inaccessible. This cross-sectional study aimed to explore SUD treatment retention, specifically comparing telemedicine-delivered opioid use disorder (OUD) treatment with a traditional in-person treatment delivery approach.

Methods: Patients at Cahaba Medical Care, an FQHC in Birmingham, AL with a diagnosis of OUD and undergoing buprenorphine/naloxone or buprenorphine treatment were categorized into two groups: treatment and control. The dependent variable, retention to SUD treatment, was assessed at four different time periods over 12 months to determine patient SUD consultation appointment attendance. Multiple linear regression was used to examine the relationship between SUD treatment retention and delivery mode. Correlations were obtained to assess associations between frequency of urine drug screens performed and SUD treatment retention.

Results: As the number of the urine drug screens patients received increased by 1, the number of SUD treatment program consultations patients attended increased by 0.69 (P < 0.001). There was no significant difference in SUD treatment retention between traditional in-person and telemedicine delivered approaches, however.

Conclusions: The findings of this study suggest that a telemedicine-delivered treatment program equals retention effectiveness when compared with in-person delivery. This suggests that leveraging telemedicine to treat patients with SUD could be an effective alternative for those unable to access treatment or who are less likely to attend or complete traditional in-person treatment sessions.

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Female
  • Health Services Accessibility
  • Humans
  • Male
  • Narcotic Antagonists / therapeutic use
  • Opiate Substitution Treatment* / methods
  • Opioid-Related Disorders
  • Retention in Care* / statistics & numerical data
  • Substance-Related Disorders* / therapy
  • Telemedicine*
  • Treatment Outcome

Substances

  • Narcotic Antagonists